Active-duty veterans with PTSD appear to benefit from prazosin
Naltrexone, exposure therapy have role in treating PTSD, alcohol dependence
Milnacipran and serotonin syndrome
Varenicline shows promise in treating alcohol dependence
Stimulant treatment linked to lower risk for substance disorders
Meta-analysis finds no effect of stimulants on substance abuse
Genetic ancestry helps explain disparity in depression outcomes
Metformin could protect against health risks in schizophrenia
From the FDA